A detailed history of Nbt Bank N A transactions in Abb Vie Inc. stock. As of the latest transaction made, Nbt Bank N A holds 56,766 shares of ABBV stock, worth $10.2 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares
56,766
Previous 58,122 2.33%
Holding current value
$10.2 Million
Previous $9.97 Million 12.45%
% of portfolio
0.76%
Previous 0.72%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $222,167 - $270,291
-1,356 Reduced 2.33%
56,766 $11.2 Million
Q2 2024

Jul 30, 2024

SELL
$154.79 - $180.76 $714,975 - $834,930
-4,619 Reduced 7.36%
58,122 $9.97 Million
Q1 2024

Apr 24, 2024

SELL
$159.82 - $182.1 $407,860 - $464,719
-2,552 Reduced 3.91%
62,741 $11.4 Million
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $44,995 - $50,675
327 Added 0.5%
65,293 $10.1 Million
Q3 2023

Oct 26, 2023

BUY
$133.59 - $154.65 $3.98 Million - $4.61 Million
29,785 Added 84.66%
64,966 $9.68 Million
Q2 2023

Jul 24, 2023

SELL
$132.51 - $164.9 $139,002 - $172,980
-1,049 Reduced 2.9%
35,181 $4.74 Million
Q1 2023

May 02, 2023

SELL
$144.61 - $166.54 $164,855 - $189,855
-1,140 Reduced 3.05%
36,230 $5.77 Million
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $113,414 - $136,013
820 Added 2.24%
37,370 $6.04 Million
Q3 2022

Nov 08, 2022

SELL
$134.21 - $153.93 $316,601 - $363,120
-2,359 Reduced 6.06%
36,550 $4.91 Million
Q2 2022

Jul 26, 2022

BUY
$137.62 - $174.96 $16,652 - $21,170
121 Added 0.31%
38,909 $5.96 Million
Q1 2022

Apr 29, 2022

SELL
$131.98 - $163.75 $119,177 - $147,866
-903 Reduced 2.28%
38,788 $6.29 Million
Q4 2021

Jan 27, 2022

SELL
$107.43 - $135.93 $2,685 - $3,398
-25 Reduced 0.06%
39,691 $5.38 Million
Q3 2021

Oct 18, 2021

SELL
$106.4 - $120.78 $74,480 - $84,546
-700 Reduced 1.73%
39,716 $4.28 Million
Q2 2021

Jul 28, 2021

SELL
$105.21 - $117.21 $38,927 - $43,367
-370 Reduced 0.91%
40,416 $4.55 Million
Q1 2021

Apr 08, 2021

SELL
$102.3 - $112.62 $302,398 - $332,904
-2,956 Reduced 6.76%
40,786 $4.41 Million
Q4 2020

Jan 15, 2021

SELL
$80.49 - $108.67 $159,048 - $214,731
-1,976 Reduced 4.32%
43,742 $4.69 Million
Q3 2020

Oct 29, 2020

BUY
$85.91 - $100.83 $124,655 - $146,304
1,451 Added 3.28%
45,718 $4.01 Million
Q2 2020

Jul 22, 2020

SELL
$73.37 - $98.18 $153,049 - $204,803
-2,086 Reduced 4.5%
44,267 $4.35 Million
Q1 2020

Apr 23, 2020

SELL
$64.5 - $97.79 $151,317 - $229,415
-2,346 Reduced 4.82%
46,353 $3.53 Million
Q4 2019

Feb 05, 2020

BUY
$72.13 - $90.25 $33,324 - $41,695
462 Added 0.96%
48,699 $4.31 Million
Q3 2019

Nov 12, 2019

SELL
$62.98 - $75.72 $57,437 - $69,056
-912 Reduced 1.86%
48,237 $3.65 Million
Q2 2019

Aug 07, 2019

SELL
$65.7 - $83.98 $23,520 - $30,064
-358 Reduced 0.72%
49,149 $3.57 Million
Q1 2019

May 06, 2019

SELL
$77.14 - $90.79 $285,803 - $336,376
-3,705 Reduced 6.96%
49,507 $3.99 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $144,022 - $177,618
-1,850 Reduced 3.36%
53,212 $4.91 Million
Q3 2018

Nov 09, 2018

SELL
$88.91 - $98.84 $434,592 - $483,129
-4,888 Reduced 8.15%
55,062 $5.21 Million
Q2 2018

Jul 31, 2018

SELL
$89.78 - $106.23 $915,486 - $1.08 Million
-10,197 Reduced 14.54%
59,950 $5.55 Million
Q1 2018

May 22, 2018

SELL
$92.01 - $123.21 $375,400 - $502,696
-4,080 Reduced 5.5%
70,147 $6.64 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $783,829 - $859,533
-8,752 Reduced 10.55%
74,227 $7.18 Million
Q3 2017

Nov 07, 2017

SELL
$69.85 - $89.22 $42,748 - $54,602
-612 Reduced 0.73%
82,979 $7.37 Million
Q2 2017

Aug 08, 2017

BUY
N/A
83,591
83,591 $6.06 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Nbt Bank N A Portfolio

Follow Nbt Bank N A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nbt Bank N A , based on Form 13F filings with the SEC.

News

Stay updated on Nbt Bank N A with notifications on news.